Results of treatment and criteria of progress of respiratory organs sarkoidosis

The aim of the work. This research work is devoted to the development of new additional criteria for the activity of inflammatory process in sarcoidosis of respiratory organs. The goal is to assess the effectiveness of performed treatment of sarcoidosis of respiratory organs by using low-cost highly...

Full description

Bibliographic Details
Main Authors: Kostiantyn Shvets, Mykola Ostrovskyy
Format: Article
Language:English
Published: PC Technology Center 2018-04-01
Series:ScienceRise: Medical Science
Subjects:
Online Access:http://journals.uran.ua/sr_med/article/view/127681
id doaj-034e72417d4d4a9793d56dd6e94cc41e
record_format Article
spelling doaj-034e72417d4d4a9793d56dd6e94cc41e2020-11-25T02:31:36ZengPC Technology CenterScienceRise: Medical Science2519-478X2519-47982018-04-0103 (23)333810.15587/2519-4798.2018.127681127681Results of treatment and criteria of progress of respiratory organs sarkoidosisKostiantyn Shvets0Mykola Ostrovskyy1ДВНЗ «Івано-Франківський національний медичний університет» вул. Галицька, 2, м. Івано-Франківськ, Україна, 76000ДВНЗ «Івано-Франківський національний медичний університет» вул. Галицька, 2, м. Івано-Франківськ, Україна, 76000The aim of the work. This research work is devoted to the development of new additional criteria for the activity of inflammatory process in sarcoidosis of respiratory organs. The goal is to assess the effectiveness of performed treatment of sarcoidosis of respiratory organs by using low-cost highly-sensitive inflammatory markers. Materials and methods. The study involved 68 patients with lung sarcoidosis before and after the three-month treatment. In addition to general-clinical methods of examination, in patients with sarcoidosis we also determined the levels of TNF-α and IL-2. Results. Patients with active lung sarcoidosis had 2.61 times (p<0.05) increased level of IL-2 in bronchoalveolar lavage fluid and 9.05 times (p<0.05) increased levels in peripheral blood serum; the levels of TNF-α increased by 4.98 times (p<0.05) in bronchoalveolar lavage fluid and by 3.2 times (p<0.05) in peripheral blood serum as compared to the findings in the control group of patients. The study showed that in the group of patients, where the efficacy of the prescribed therapy was noted, the level of IL-2 decreased by 2.08 times (p<0.05) in bronchoalveolar lavage fluid and by 3.76 times (p<0.05) in peripheral blood serum, and the concentration of TNF-α decreased by 3.87 times (p<0.05) in bronchoalveolar lavage fluid and by 2.06 times in peripheral blood serum as compared to the initial indices. Conclusions. The decrease of TNF-α level in bronchoalveolar lavage fluid on the background of three-months treatment correlated (r=0.84; p<0.05) to the changes in peripheral blood serum; at the same time the decrease of TNF-α level in peripheral blood serum correlated (r=0.89; p<0.05) to the decrease of IL-2 in peripheral blood serum of patients with sarcoidosis of respiratory organshttp://journals.uran.ua/sr_med/article/view/127681саркоїдоз органів диханнямаркери активностіформування прогнозулікуванняінтерлейкін-2
collection DOAJ
language English
format Article
sources DOAJ
author Kostiantyn Shvets
Mykola Ostrovskyy
spellingShingle Kostiantyn Shvets
Mykola Ostrovskyy
Results of treatment and criteria of progress of respiratory organs sarkoidosis
ScienceRise: Medical Science
саркоїдоз органів дихання
маркери активності
формування прогнозу
лікування
інтерлейкін-2
author_facet Kostiantyn Shvets
Mykola Ostrovskyy
author_sort Kostiantyn Shvets
title Results of treatment and criteria of progress of respiratory organs sarkoidosis
title_short Results of treatment and criteria of progress of respiratory organs sarkoidosis
title_full Results of treatment and criteria of progress of respiratory organs sarkoidosis
title_fullStr Results of treatment and criteria of progress of respiratory organs sarkoidosis
title_full_unstemmed Results of treatment and criteria of progress of respiratory organs sarkoidosis
title_sort results of treatment and criteria of progress of respiratory organs sarkoidosis
publisher PC Technology Center
series ScienceRise: Medical Science
issn 2519-478X
2519-4798
publishDate 2018-04-01
description The aim of the work. This research work is devoted to the development of new additional criteria for the activity of inflammatory process in sarcoidosis of respiratory organs. The goal is to assess the effectiveness of performed treatment of sarcoidosis of respiratory organs by using low-cost highly-sensitive inflammatory markers. Materials and methods. The study involved 68 patients with lung sarcoidosis before and after the three-month treatment. In addition to general-clinical methods of examination, in patients with sarcoidosis we also determined the levels of TNF-α and IL-2. Results. Patients with active lung sarcoidosis had 2.61 times (p<0.05) increased level of IL-2 in bronchoalveolar lavage fluid and 9.05 times (p<0.05) increased levels in peripheral blood serum; the levels of TNF-α increased by 4.98 times (p<0.05) in bronchoalveolar lavage fluid and by 3.2 times (p<0.05) in peripheral blood serum as compared to the findings in the control group of patients. The study showed that in the group of patients, where the efficacy of the prescribed therapy was noted, the level of IL-2 decreased by 2.08 times (p<0.05) in bronchoalveolar lavage fluid and by 3.76 times (p<0.05) in peripheral blood serum, and the concentration of TNF-α decreased by 3.87 times (p<0.05) in bronchoalveolar lavage fluid and by 2.06 times in peripheral blood serum as compared to the initial indices. Conclusions. The decrease of TNF-α level in bronchoalveolar lavage fluid on the background of three-months treatment correlated (r=0.84; p<0.05) to the changes in peripheral blood serum; at the same time the decrease of TNF-α level in peripheral blood serum correlated (r=0.89; p<0.05) to the decrease of IL-2 in peripheral blood serum of patients with sarcoidosis of respiratory organs
topic саркоїдоз органів дихання
маркери активності
формування прогнозу
лікування
інтерлейкін-2
url http://journals.uran.ua/sr_med/article/view/127681
work_keys_str_mv AT kostiantynshvets resultsoftreatmentandcriteriaofprogressofrespiratoryorganssarkoidosis
AT mykolaostrovskyy resultsoftreatmentandcriteriaofprogressofrespiratoryorganssarkoidosis
_version_ 1724823403657953280